BACH BOLIGCENTER ApS: Financial statements 2024
CVR: 12024584
Source: annual report 2024, Danish Business Authority
01/05/2023 – 31/03/2024
BACH BOLIGCENTER ApS (CVR 12024584) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -19,656 and a net result of DKK 38,084 compared with DKK -200,720 the year before. Equity in the 2024 report amounted to DKK 403,549. The solvency ratio was 95.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -19,656
- Profit/Loss
- DKK 38,084
- Equity
- DKK 403,549
- Total Assets
- DKK 421,377
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -20K | 38K | 404K | 1 |
| 2023 | - | -15K | -201K | 424K | 1 |
| 2022 | - | -14K | -153K | 682K | 1 |
| 2021 | - | -13K | -9K | 892K | 1 |
| 2020 | - | -14K | -166K | 956K | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout BACH BOLIGCENTER ApS
BACH BOLIGCENTER ApS is a Danish company of the type Anpartsselskab based in Hammel, founded in 1988. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named EMBRYODAN ApS. The management consists of Geo Koch. The company is owned by Geo Koch. The company has 1 employee (2023). In 2026, the company reported a gross profit of DKK -12,635 and a net result of DKK 3,958 compared with DKK -35,885 the year before. Equity in the 2026 report amounted to DKK 243,122.
